Key autophagic targets and relevant small-molecule compounds in cancer therapy

Cell Proliferation

Volumn 48, Issue 1, 2015, Pages 7-16

  Tong, X P ^a,d   Chen, Y ^a   Zhang, S Y ^a   Xie, T ^a   Tian, M ^a   Guo, M R ^a   Kasimu, R ^b   Ouyang, L ^a   Wang, J H ^b,c  

^a SICHUAN UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^d CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZD 8055; BECLIN 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; METFORMIN; ORIDONIN; PROTEIN KINASE B; PROTEIN P53; RAPAMYCIN; ROTTLERIN; TAMOXIFEN; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MOLECULAR LIBRARY;

ARTICLE; AUTOPHAGY; CANCER THERAPY; CELL DEATH; CELL SURVIVAL; DRUG TARGETING; HUMAN; NONHUMAN; ANIMAL; METABOLISM; MOLECULAR LIBRARY; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION; THERAPEUTIC USE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; SIGNAL TRANSDUCTION; SMALL MOLECULE LIBRARIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84920990882     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12154     Document Type: Article

References (86)

1. Klionsky DJ (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 8, 931-937.
2. Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxid. Redox Signal. 20, 460-473.
3. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42.
4. Liu B, Wen X, Cheng Y (2013) Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer. Cell Death Dis. 4, e892.
5. Liu B, Cheng Y, Liu Q, Bao JK, Yang JM (2010) Autophagic pathways as new targets for cancer drug development. Acta Pharmacol. Sin. 31, 1154-1164.
6. Huang J, Klionsky DJ (2007) Autophagy and human disease. Cell Cycle 6, 1837-1849.
7. Rabinowitz JD, White E (2010) Autophagy and metabolism. Science 330, 1344-1348.
8. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R et al. (2009) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 16, 87-93.
9. Feng Y, He D, Yao Z, Klionsky DJ (2014) The machinery of macroautophagy. Cell Res. 1, 24-41.
10. Hara T, Takamura A, Kishi C, Iemura S, Natsume T, Guan JL et al. (2008) FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J. Cell Biol. 181, 497-510.
11. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J et al. (2009) ULK-Atg13-FIP200 complexes mediate mTORC1 signaling to the autophagy machinery. Mol. Biol. Cell 20, 1992-2003.
12. Hosokawa N, Sasaki T, Iemura S, Natsume T, Hara T, Mizushima N (2009) Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy 5, 973-979.
13. Martina JA, Chen Y, Gucek M, Puertollano R (2012) MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8, 903-914.
14. Itakura E, Kishi C, Inoue K, Mizushima N (2008) Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol. Biol. Cell 19, 5360-5372.
15. Fu LL, Cheng Y, Liu B (2013) Beclin-1: autophagic regulator and therapeutic target in cancer. Int. J. Biochem. Cell Biol. 45, 921-924.
16. Nazio F, Cecconi F (2013) mTOR, AMBRA1, and autophagy: an intricate relationship. Cell Cycle 12, 2524-2525.
17. Kang R, Zeh HJ, Lotze MT, Tang D (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 18, 571-580.
18. Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD et al. (1998) A protein conjugation system essential for autophagy. Nature 395, 395-398.
19. Mizushima N, Kuma A, Kobayashi Y, Yamamoto A, Matsubae M, Takao T et al. (2003) Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell Sci. 116, 1679-1688.
20. Geng J, Klionsky DJ (2008) The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. EMBO Rep. 9, 859-864.
21. Reggiori F, Tucker KA, Stromhaug PE, Klionsky DJ (2004) The Atg1-Atg13 complex regulates Atg9 and Atg23 retrieval transport from the pre-autophagosomal structure. Dev. Cell 6, 79-90.
22. Satoo K, Noda NN, Kumeta H, Fujioka Y, Mizushima N, Ohsumi Y et al. (2009) The structure of Atg4B-LC3 complex reveals the mechanism of LC3 processing and delipidation during autophagy. EMBO J. 28, 1341-1350.
23. Atlashkin V, Kreykenbohm V, Eskelinen E-L, Wenzel D, Fayyazi A, Fischer von Mollard G (2003) Deletion of the SNARE vti1b in mice results in the loss of a single SNARE partner, syntaxin 8. Mol. Cell. Biol. 23, 5198-5207.
24. Furuta N, Fujita N, Noda T, Yoshimori T, Amano A (2010) Combinational soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins VAMP8 and Vti1b mediate fusion of antimicrobial and canonical autophagosomes with lysosomes. Mol. Biol. Cell 21, 1001-1010.
25. Itakura E, Kishi-Itakura C, Mizushima N (2012) The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151, 1256-1269.
26. Wang SY, Yu QJ, Zhang RD, Liu B (2011) Core signaling pathways of survival/death in autophagy-related cancer networks. Int. J. Biochem. Cell Biol. 43, 1263-1266.
27. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC et al. (2009) Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta 1793, 1524-1532.
28. McCarthy N (2014) Autophagy: directed development. Nat. Rev. Cancer 14, 74-75.
29. Ren XS, Sato Y, Harada K, Sasaki M, Furubo S, Song JY et al. (2014) Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat. PLoS One 9, e87660.
30. Lin Z, Liu T, Kamp DW, Wang Y, He H, Zhou X et al. (2014) AKT/mTOR and C- N-terminal kinase (JNK) signaling pathways are required for chrysotile asbestos-induced autophagy. Free Radic. Biol. Med. 72, 296-307.
31. Nho RS, Hergert P (2014) IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt/mTOR kinases. PLoS One 9, e94616.
32. Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35.
33. Ciuffreda L, Di Sanza C, Incani UC, Milella M (2010) The mTOR pathway: a new target in cancer therapy. Curr. Cancer Drug Targets 10, 484-495.
34. Hartford CM, Ratain MJ (2007) Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin. Pharmacol. Ther. 82, 381-388.
35. Liu Q, Thoreen C, Wang J, Sabatini D, Gray NS (2009) mTOR mediated anti-cancer drug discovery. Drug Discov. Today Ther. Strateg. 6, 47-55.
36. Ku F, McConkey DJ, Hong DS, Kurzrock R (2011) Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol. 8, 528-539.
37. Rubinsztein DC, Codogno P, Levine B (2012) Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11, 709-730.
38. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG et al. (2009) Screen for chemical modulators of autophagy reveals el therapeutic inhibitors of mTORC1 signaling. PLoS One 4, e7124.
39. Apsel B, Blair JA, Gonzalez B, Nazif TM, Feldman ME, Aizenstein B et al. (2008) Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat. Chem. Biol. 4, 691-699.
40. Bomeddy A, Hahm ER, Xiao D, Powolny AA, Fisher AL, Jiang Y et al. (2009) Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res. 69, 3704-3712.
41. Raviku B, Stewart A, Kita H, Kato K, Duden R, Rubinsztein DC (2003) Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by reasing mTOR phosphorylation and inducing autophagy. Hum. Mol. Genet. 12, 985-994.
42. Salazar M, Carracedo A, Salanueva IJ, Hernández-Tiedra S, Lorente M, Egia A et al. (2009) Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119, 1359-1372.
43. Scarlatti F, Maffei R, Beau I, Codogno P, Ghidoni R (2008) Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ. 15, 1318-1329.
44. Bareford MD, Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N et al. (2011) Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res. 71, 4955-4967.
45. Liu TJ, Koul D, LaFortune T, Tiao N, Shen RJ, Maira SM et al. (2009) NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Mol. Cancer Ther. 8, 2204-2210.
46. Fan QW, Cheng C, Hackett C, Feldman M, Houseman BT, Nicolaides T et al. (2010) Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci. Signal. 3, ra81.
47. García-tínez JM, Moran J, Clarke RG, Gray A, Cosulich SC, Chresta CM et al. (2009) Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR). Biochem. J. 421, 29-42.
48. Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, Oscarsson J et al. (2009) Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ. 16, 1018-1029.
49. Li HB, Yi X, Gao JM, Ying XX, Guan HQ, Li JC (2007) Magnolol-induced H460 cells death via autophagy but not apoptosis. Arch. Pharm. Res. 30, 1566-1574.
50. Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L et al. (2009) The inositol 1, 4, 5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ. 16, 1006-1017.
51. Li H, Wang P, Sun Q, Ding WX, Yin XM, Sobol RW et al. (2011) Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res. 71, 3625-3634.
52. McKnight NC, Zhenyu Y (2013) Beclin 1, an essential component and master regulator of PI3K-III in health and disease. Curr. Pathobiol. Rep. 1, 231-238.
53. Li X, He L, Che KH, Funderburk SF, Pan L, Pan N et al. (2012) Imperfect interface of Beclin1 coiled-coil domain regulates homodimer and heterodimer formation with Atg14L and UVRAG. Nat. Commun. 3, 662.
54. Di Bartolomeo S, Corazzari M, Nazio F, Oliverio S, Lisi G, Antonioli M et al. (2010) The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J. Cell Biol. 19, 155-168.
55. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P et al. (2010) Endogenous HMGB1 regulates autophagy. J. Cell Biol. 190, 881-892.
56. Mobahat M, Narendran A, Riabowol K (2014) Survivin as a preferential target for cancer therapy. Int. J. Mol. Sci. 15, 2494-2516.
57. Michiorri S, Gelmetti V, Giarda E, Lombardi F, Romano F, Marongiu R et al. (2010) The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ. 17, 962-974.
58. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al. (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939.
59. Sun Q, Zhang J, Fan W, Wong KN, Ding X, Chen S et al. (2011) The RUN domain of rubicon is important for hVps34 binding, lipid kinase inhibition, and autophagy suppression. J. Biol. Chem. 286, 185-191.
60. Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L et al. (2011) Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 147, 223-234.
61. Malik SA, Orhon I, Morselli E, Criollo A, Shen S, Mariño G et al. (2011) BH3 mimetics activate multiple pro-autophagic pathways. Oncogene 30, 3918-3929.
62. Hoyer-Hansen M, Bastholm L, Mathiasen IS, Elling F, Jaattela M (2005) Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ. 12, 1297-1309.
63. Lian J, Wu X, He F, Karnak D, Tang W, Meng Y et al. (2011) A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ. 18, 60-71.
64. Wienecke R, Fackler I, Linsenmaier U, Linsenmaier U, Mayer K, Licht T et al. (2006) Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am. J. Kidney Dis. 48, e27-e29.
65. Crazzolara R, Bradstock KF, Bendall LJ (2009) RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia. Autophagy 5, 727-728.
66. Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H, Meijer AJ (1997) The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 243, 240-246.
67. Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR et al. (2010) Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J. Biol. Chem. 285, 10850-10861.
68. Shang LB, Wang XD (2011) AMPK and mTOR coordinate the regulation of Ulk1 and mammalian autophagy initiation. Autophagy 7, 924-926.
69. Jiang L, Sheikh MS, Huang Y (2010) Decision making by p53: life versus death. Mol. Cell Pharmacol. 2, 69-77.
70. Ryan KM (2011) P53 and autophagy in cancer: guardian of the genome meets guardian of the proteome. Eur. J. Cancer 47, 44-50.
71. Feng Z, Zhang H, Levine AJ, Jin S (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. USA 102, 8204-8209.
72. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR et al. (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126, 121-134.
73. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144.
74. Yee KS, Wilkinson S, James J, Ryan KM, Vousden KH (2009) PUMA and Bax-induced autophagy contributes to apoptosis. Cell Death Differ. 16, 1135-1145.
75. Sui X, Jin L, Huang X, Geng S, He C, Hu X (2011) P53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment. Autophagy 7, 565-571.
76. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M et al. (2008) Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10, 676-687.
77. Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A et al. (2008) Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 19, 3056-3061.
78. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107-120.
79. Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G (2010) Autophagy regulation by p53. Cur. Opin. Cell Biol. 22, 181-185.
80. Ye YC, Wang HJ, Xu L (2012) Oridonin induces apoptosis and autophagy in murine fibrosarcoma L929 cells partly via NO-ERK-p53 positive-feedback loop signaling pathway. Acta Pharmacol. Sin. 33, 1055-1061.
81. Liu Y, Yang Y, Ye YC, Shi QF, Chai K, Tashiro S et al. (2012) Activation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-Met inhibitor SU11274 in human lung cancer A549 cells. J. Pharmacol. Sci. 118, 423-432.
82. Wen M, Wu J, Luo H, Zhang H (2012) Galangin induces autophagy through upregulation of p53 in HepG2 cells. Pharmacology 89, 247-255.
83. Janjetovic K, Harhaji-Trajkovic L, Misirkic-Marjanovic M, Vucicevic L, Stevanovic D, Zogovic N et al. (2011) In vitro and in vivo anti-melanoma action of metformin. Eur. J. Pharmacol. 668, 373-382.
84. Wang N, Pan W, Zhu M, Zhang M, Hao X, Liang G et al. (2011) Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br. J. Pharmacol. 164, 731-742.
85. Yang YF, Wu CC, Chen WP, Chen YL, Su MJ (2011) Prazosin induces p53-mediated autophagic cell death in H9C2 cells. Naunyn Schmiedebergs Arch. Pharmacol. 384, 209-216.
86. Li X, Wu WK, Sun B, Cui M, Liu S, Gao J et al. (2011) Dihydroptychantol A, a macrocyclic bisbibenzyl derivative, induces autophagy and following apoptosis associated with p53 pathway in human osteosarcoma U2OS cells. Toxicol. Appl. Pharmacol. 251, 146-154.